Quick Order Cart

Cat. No. ARG39284

DNAJC25 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

DNAJC25 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the SK-HEP-1 human hepatic adenocarcinoma line with endothelial characteristics. This model disrupts DNAJC25, a DnaJ co-chaperone that partners with Hsp70 (HSPA1A) and BiP (HSPA5) to regulate protein folding and the unfolded protein response, with links to ATF6 and XBP1 signaling. These cells are ideal for studying co-chaperone function in hepatocellular carcinoma and ER stress. Applications include western blotting, RT-qPCR, apoptosis assays, and drug sensitivity studies, enabling research into protein quality control and liver cancer biology.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    DNAJC25

    Gene Identifier

    NCBI Gene ID 548645

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC25 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the DNAJC25 gene. This heterogeneous pool of SK-HEP-1 cells serves as a loss-of-function model to study the gene’s role without the selective pressures of clonal isolation, making it suitable for experiments requiring population-level genetic diversity.

The SK-HEP-1 parental line is a human hepatic adenocarcinoma cell line with endothelial characteristics, derived from ascites of a hepatocellular carcinoma patient. It recapitulates features of liver sinusoidal endothelial cells, enabling research on hepatic vascular function and tumor microenvironment interactions. This unique model bridges cancer biology and endothelial cell studies within the liver.

DNAJC25 encodes a DnaJ co-chaperone that partners with Hsp70 family proteins, including HSPA1A and HSPA5/BiP, to mediate protein folding and ER quality control. It functions within the unfolded protein response (UPR) network, regulated by ATF6, IRE1??/XBP1, and PERK/eIF2??/ATF4 pathways. Disruption of DNAJC25 compromises Hsp70 chaperone complexes, impairs the clearance of misfolded proteins via ERAD, and sensitizes cells to ER stress-induced apoptosis, highlighting its pivotal role in maintaining proteostasis.

In the SK-HEP-1 background, DNAJC25 knockout is particularly informative for dissecting how co-chaperone dysfunction influences hepatocellular carcinoma progression and endothelial cell responses. The model can be used to investigate ER stress-mediated effects on cancer cell proliferation, migration, and drug resistance, as well as on endothelial barrier function and tumor angiogenesis. These studies are relevant to understanding liver cancer biology and ER stress-related disorders.

Typical applications include western blotting for DNAJC25 and UPR markers, RT-qPCR for UPR target genes, immunofluorescence for ER stress markers, and flow cytometry for apoptosis. The cells are also suited for migration/invasion assays and drug sensitivity screens with ER stress inducers. For more information or to place an order, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)